We are live on
!
Find out more
BG
Bahl & Gaynor Portfolio holdings
AUM
$19.8B
1-Year Est. Return
19.53%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.38B
AUM Growth
+$231M
(+3.2%)
Cap. Flow
+$238M
Cap. Flow
% of AUM
3.22%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
443
New
26
Increased
211
Reduced
155
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$135M |
| 2 |
PepsiCo
PEP
|
+$65.3M |
| 3 |
PNC Financial Services
PNC
|
+$61.9M |
| 4 |
Home Depot
HD
|
+$55.7M |
| 5 |
Hasbro
HAS
|
+$48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$80.6M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.1M |
| 3 |
US Bancorp
USB
|
+$65.3M |
| 4 |
McDonald's
MCD
|
+$50.1M |
| 5 |
Oneok
OKE
|
+$49.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.18% |
| 2 | Consumer Staples | 15.63% |
| 3 | Technology | 14.71% |
| 4 | Financials | 12.61% |
| 5 | Industrials | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
ResMed
RMD
$32.5B
| $8.7M | 0.12% |
121,140
-3,473
| -3% | -$226K |
|
102
iShares MSCI KLD 400 Social ETF
DSI
$5.52B
| $8.21M | 0.11% |
212,478
-6,354
| -3% | -$244K |
|
103
AT&T
T
$158B
| $8.15M | 0.11% |
330,539
-14,760
| -4% | -$375K |
|
104
Berkshire Hathaway Class B
BRK.B
$1.12T
| $7.71M | 0.1% |
53,445
+317
| +0.6% | +$46.6K |
|
105
IBM
IBM
$222B
| $7.5M | 0.1% |
48,845
-35,226
| -42% | -$5.34M |
|
106
Teleflex
TFX
$6.06B
| $7.45M | 0.1% |
61,675
-1,302
| -2% | -$151K |
|
107
Healthcare Services Group
HCSG
$1.57B
| $7.35M | 0.1% |
228,715
-11,629
| -5% | -$376K |
|
108
Enbridge
ENB
$113B
| $6.73M | 0.09% |
138,747
-12,171
| -8% | -$585K |
|
109
Gentex
GNTX
$5.14B
| $6.48M | 0.09% |
354,309
+37,995
| +12% | +$670K |
|
|
SIAL
110
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $6M | 0.08% |
43,378
-3,305
| -7% | -$456K |
|
|
FISV
111
Fiserv Inc
FISV
$28.9B
| $5.81M | 0.08% |
146,458
-2,298
| -2% | -$87.6K |
|
112
Realty Income
O
$58.5B
| $5.58M | 0.08% |
111,599
-11,327
| -9% | -$567K |
|
|
DD
113
DELISTED
Du Pont De Nemours E I
DD
| $5.27M | 0.07% |
77,655
-34,558
| -31% | -$2.47M |
|
114
iShares US Technology ETF
IYW
$24.9B
| $5.27M | 0.07% |
200,744
-1,256
| -0.6% | -$33K |
|
115
Evercore
EVR
$12.3B
| $5.19M | 0.07% |
100,474
+52,729
| +110% | +$2.68M |
|
|
RDS.A
116
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $5.15M | 0.07% |
92,403
+1,098
| +1% | +$65K |
|
117
Lowe's Companies
LOW
$123B
| $4.99M | 0.07% |
67,065
-8,670
| -11% | -$622K |
|
118
BOK Financial
BOKF
$8.78B
| $4.93M | 0.07% |
80,590
-34,169
| -30% | -$1.99M |
|
|
SNI
119
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $4.75M | 0.06% |
69,223
-8,997
| -12% | -$654K |
|
120
W.P. Carey
WPC
$16.4B
| $4.65M | 0.06% |
69,833
+9,586
| +16% | +$659K |
|
|
FITB
121
Fifth Third Bancorp
FITB
$52.2B
| $4.48M | 0.06% |
237,507
-17,233
| -7% | -$325K |
|
|
122
Berkshire Hathaway Class A
BRK.A
$1.12T
| $4.35M | 0.06% |
20
| – | – |
|
123
Steris
STE
$22.7B
| $4.26M | 0.06% |
60,576
-661
| -1% | -$43.6K |
|
124
Targa Resources
TRGP
$55.8B
| $4.22M | 0.06% |
44,109
+423
| +1% | +$39.7K |
|
|
SLH
125
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $4.19M | 0.06% |
81,113
+67,473
| +495% | +$3.56M |
|
Similar funds
NIM
HHII
SPIA
MIM
EIM
OSAM
P
Bahl & Gaynor's Q1 2015 Portfolio in Review
As of Q1 2015, Bahl & Gaynor held 443 positions worth $7.38B, up 3.2% from $7.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Bahl & Gaynor deployed $238M of net new capital in Q1 2015, opening 26 new positions and adding to 211 existing holdings. Its largest new stake was Blackstone: 24,777 shares worth $946K.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Baxter International, an estimated $80.6M trimmed.
- Bahl & Gaynor's largest Q1 2015 buy was Blackstone: 24,777 shares worth $946K.
- Bahl & Gaynor added most to Pfizer in Q1 2015, an estimated $135M increase.
- Bahl & Gaynor's biggest Q1 2015 reduction was Baxter International, cutting an estimated $80.6M.
- Bahl & Gaynor fully exited MWI VETERINARY SUPPLY, INC. in Q1 2015, selling an estimated $650K.
- Bahl & Gaynor's ten largest holdings make up 24% of its $7.38B portfolio in Q1 2015.
- Bahl & Gaynor opened 26 new positions and closed 11 in Q1 2015.
- Bahl & Gaynor's portfolio value rose 3.2% quarter-over-quarter to $7.38B.
Based on Bahl & Gaynor's 13F filing for Q1 2015, filed 12 May 2015.